BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 980178)

  • 1. Immune response to rauscher virus-induced leukemia in DBA mice. I. Role of cellular and humoral immunity in spontaneous regression.
    Tóth FD; Gomba S; Váczi L; Kása M; Jakó J
    Neoplasma; 1976; 23(5):471-81. PubMed ID: 980178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to Rauscher virus-induced leukemia in DBA mice. II. Correlation between antigenic expression and pathogenesis.
    Tóth FD; Váczi L
    Neoplasma; 1978; 25(3):265-72. PubMed ID: 79984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anti-lymphocyte and anti-thymocyte serum on the pathogenesis of Rauscher leukaemia in inbred mouse strains.
    Váczi L; Leövey A; Tóth FD; Kása M
    Acta Microbiol Acad Sci Hung; 1976; 23(4):309-16. PubMed ID: 1088332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of Rauscher leukaemia virus on the immune system in susceptible and resistant mouse strains.
    Tóth FD; Karsai T; Váczi L
    Acta Microbiol Acad Sci Hung; 1971; 18(4):271-8. PubMed ID: 4136204
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults.
    McCoy JL; Fefer A; Ting RC; Glynn JP
    Cancer Res; 1972 Aug; 32(8):1671-8. PubMed ID: 4339747
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of cellular and humoral immunity in mice infected with Rauscher leukemia virus following administration of serum against isologous aggregated immunoglobulins].
    Snegireva AE; Khorobrykh VV; Kaulen DR; Merimskaia OS; Shevliagin VIa
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (7):27-33. PubMed ID: 6967739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antilymphocytic humoral autoimmune response of mice with developing Rauscher leukemia directed against group-specific retrovirus antigens].
    Ter-Grigorov VS; Graf IA; Pivnik AV; Etkin AF; Moskovkina OIa
    Eksp Onkol; 1987; 9(6):48-51. PubMed ID: 3325268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation of 7S-immunoglobulins (IgG), detected in spleen cells and sera of mice in the early stages of Rauscher leukemia].
    Ter-Grigorov VS; Dzagurov SG; Dorfman NA; Shevelev BI
    Biull Eksp Biol Med; 1974 Nov; 78(11):82-5. PubMed ID: 4614878
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course].
    Ter-Grigorov VS; Dzagurov SG; Shevelev BI
    Biull Eksp Biol Med; 1975 Feb; 79(2):76-80. PubMed ID: 48386
    [No Abstract]   [Full Text] [Related]  

  • 14. Inheritance of susceptibility and resistance to Rauscher leukaemia virus.
    Tóth FD; Váczi L; Balogh M
    Acta Microbiol Acad Sci Hung; 1973; 20(3):183-9. PubMed ID: 4798829
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor.
    Kobrin BJ; Naor D; Klein BY
    J Immunol; 1981 May; 126(5):1874-82. PubMed ID: 6260859
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-associated membrane antigens and the antitumor immune reactions.
    Levy JP; Kourilsky FM
    Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
    [No Abstract]   [Full Text] [Related]  

  • 18. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 20. [A peculiarity in the humoral immunity of BALB/C mice with Rauscher leukemia].
    Sokolov PP; Bergol'ts VM
    Biull Eksp Biol Med; 1976 Mar; 81(3):356-8. PubMed ID: 1085178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.